Physician profile
William Malcolm Granberry
NPI 1134162605
$83,898.70
in general payments reported to CMS, 2019-2025
13 companies · $2,930 in 2025
The $2,930 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $18K · 2021: $8,975 · 2022: $8,471 · 2023: $5,296 · 2024: $7,283 · 2025: $2,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $11K · Food and Beverage: $2,212 · Travel and Lodging: $1,921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $11,375.24 |
| Food and Beverage | $2,211.83 |
| Travel and Lodging | $1,920.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $77,677.11 | 2019-2025 | Arthrex |
| Medinc of Texas | $3,019.22 | 2019-2025 | |
| Stryker Corporation | $1,845.43 | 2019-2025 | Infinity, Mako, Salvation |
| Paragon 28, INC. | $796.49 | 2022-2025 | Portfolio, Apex 3d, Plating Portfolio |
| Wright Medical Technology, INC. | $134.77 | 2019-2020 | |
| Depuy Synthes Sales INC. | $112.38 | 2019-2024 | Na |
| Bioventus LLC | $70.17 | 2020-2025 | Durolane |
| Treace Medical Concepts, INC. | $69.65 | 2023-2024 | |
| Ossur Americas, INC. | $49.26 | 2024 | |
| Smith+Nephew, INC. | $47.36 | 2025 | Collagenase Santyl |
| Globus Medical, INC. | $39.86 | 2025 | Anthem |
| Acumed LLC | $37.00 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Granberry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.